Axogen, Inc. Operating Lease Cost
Axogen, Inc. (AXGN) reported Operating Lease Cost of $949.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-07-29
- Axogen, Inc. operating lease, cost for the quarter ending 2026-06-30 was $949.00K, a 3.26% increase year-over-year.
- Axogen, Inc. operating lease, cost for the quarter ending 2026-03-31 was $942.00K, a 3.40% increase year-over-year.
- Axogen, Inc. operating lease, cost for the quarter ending 2025-12-31 was $960.00K, a 4.46% increase year-over-year.
- Axogen, Inc. operating lease, cost for the quarter ending 2025-09-30 was $919.00K, a 0.00% change year-over-year.
- Axogen, Inc. operating lease, cost for fiscal 2025 was $3.71M, a 1.23% increase from fiscal 2024.
- Axogen, Inc. operating lease, cost for fiscal 2024 was $3.66M, a 10.49% increase from fiscal 2023.
- Axogen, Inc. operating lease, cost for fiscal 2023 was $3.32M, a 18.67% decline from fiscal 2022.
- Axogen, Inc. operating lease, cost for fiscal 2022 was $4.08M, a 5.76% decline from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $949.00K 10-Q · filed 2026-07-29 | $1.89M 10-Q · filed 2026-07-29 | $2.85M derived: sum of 3 quarters · filed 2026-07-29 | $3.77M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $942.00K 10-Q · filed 2026-04-28 | $1.90M derived: sum of 2 quarters · filed 2026-04-28 | $2.82M derived: sum of 3 quarters · filed 2026-04-28 | $3.74M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $960.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.88M derived: sum of 2 quarters · filed 2026-02-24 | $2.80M derived: sum of 3 quarters · filed 2026-07-29 | $3.71M 10-K · filed 2026-02-24 |
| 2025-09-30 | $919.00K 10-Q · filed 2025-10-29 | $1.84M derived: sum of 2 quarters · filed 2026-07-29 | $2.75M 10-Q · filed 2025-10-29 | $3.67M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $919.00K 10-Q · filed 2026-07-29 | $1.83M 10-Q · filed 2026-07-29 | $2.75M derived: sum of 3 quarters · filed 2026-07-29 | $3.67M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $911.00K 10-Q · filed 2026-04-28 | $1.83M derived: sum of 2 quarters · filed 2026-04-28 | $2.75M derived: sum of 3 quarters · filed 2026-04-28 | $3.67M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $919.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.84M derived: sum of 2 quarters · filed 2026-02-24 | $2.75M derived: sum of 3 quarters · filed 2026-02-24 | $3.66M 10-K · filed 2026-02-24 |
| 2024-09-30 | $919.00K 10-Q · filed 2025-10-29 | $1.84M derived: sum of 2 quarters · filed 2025-10-29 | $2.75M 10-Q · filed 2025-10-29 | |
| 2024-06-30 | $917.00K 10-Q · filed 2025-08-05 | $1.83M 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | $909.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $3.32M 10-K · filed 2026-02-24 | |||
| 2022-12-31 | $4.08M 10-K · filed 2025-02-26 | |||
| 2021-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $2.25M derived: sum of 2 quarters · filed 2024-03-05 | $3.28M derived: sum of 3 quarters · filed 2024-03-05 | $4.33M 10-K · filed 2024-03-05 |
| 2021-09-30 | $1.03M 10-Q · filed 2021-11-04 | $2.07M derived: sum of 2 quarters · filed 2021-11-04 | $3.11M 10-Q · filed 2021-11-04 | $4.21M derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-06-30 | $1.03M 10-Q · filed 2021-08-05 | $2.08M 10-Q · filed 2021-08-05 | $3.17M derived: sum of 3 quarters · filed 2023-03-14 | $3.88M derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-03-31 | $1.05M 10-Q · filed 2021-05-06 | $2.14M derived: sum of 2 quarters · filed 2023-03-14 | $2.85M derived: sum of 3 quarters · filed 2023-03-14 | $3.34M derived: sum of 4 quarters · filed 2023-03-14 |
| 2020-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.80M derived: sum of 2 quarters · filed 2023-03-14 | $2.29M derived: sum of 3 quarters · filed 2023-03-14 | $2.78M 10-K · filed 2023-03-14 |
| 2020-09-30 | $707.00K 10-Q · filed 2021-11-04 | $1.20M derived: sum of 2 quarters · filed 2021-11-04 | $1.68M 10-Q · filed 2021-11-04 | $2.14M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $491.00K 10-Q · filed 2021-08-05 | $976.00K 10-Q · filed 2021-08-05 | $1.44M derived: sum of 3 quarters · filed 2022-02-25 | $1.92M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $482.00K 10-Q · filed 2021-05-06 | $945.00K derived: sum of 2 quarters · filed 2022-02-25 | $1.43M derived: sum of 3 quarters · filed 2022-02-25 | $1.90M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $463.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $946.00K derived: sum of 2 quarters · filed 2022-02-25 | $1.42M derived: sum of 3 quarters · filed 2022-02-25 | $1.91M 10-K · filed 2022-02-25 |
| 2019-09-30 | $483.00K 10-Q · filed 2020-10-30 | $958.00K derived: sum of 2 quarters · filed 2020-10-30 | $1.45M 10-Q · filed 2020-10-30 | |
| 2019-06-30 | $475.00K 10-Q · filed 2020-08-07 | $964.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $489.00K 10-Q · filed 2020-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |